All In Biotech

Drug Trial Radar · NCT03347526

A Novel Approach to Infantile Spasms

A Novel Approach to Infantile Spasms: Combined Cosyntropin Injectable Suspension, 1 mg/mL and Vigabatrin Induction Therapy

Last checked: Nov 19, 2026Latest source record: May 27, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

SuspendedPivotal-lookingPhase 3. Randomized with 394 participants. This is a heuristic, not a regulatory label.

Status

Suspended

Enrollment

394

Planned (sponsor's estimate)

Start

Apr 19, 2018

Primary completion

Jun 2021

Study completion Aug 2021

Sponsor

Lead sponsor
University of Colorado, DenverAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Pediatric Epilepsy Research Foundation; West Therapuetics, Inc
First posted
Nov 20, 2017

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 2 months, up to 2 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study proposes to assess the efficacy of Cosyntropin Injectable Suspension, 1 mg/mL compared to vigabatrin. Additionally, this study proposes to determine efficacy of combination therapy of Cosyntropin Injectable Suspension, 1 mg/mL and vigabatrin to monotherapy Cosyntropin Injectable Suspension, 1mg/mL in children with new onset infantile spasms (IS).

Conditions

  • Infantile Spasm

Interventions

  • Cosyntropin Injectable Suspension, 1 mg/mLDrug

    Injectable

  • Cosyntropin Injectable Suspension 1 MG/ML + vigabatrinDrug

    Injectable + oral solution

  • VigabatrinDrug

    oral

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. A comparison of Cosyntropin Injectable Suspension and Vigabatrin on the proportion of subjects who become spasm-free as defined by a) and b).Time frame: 2 weeks

Locations

14 sites in 1 country. Site status is shown where the registry gives one.

  • Children's Hospital Los Angeles

    Los Angeles, California

  • UCSF Medical Center

    San Francisco, California

  • University of Colorado Anschutz Medical Campus

    Aurora, Colorado

  • Children's National Medical Center

    Washington D.C., District of Columbia

  • Children's Healthcare of Atlanta at Scottish Rite

    Atlanta, Georgia

  • Ann & Robert H. Lurie Children's Hospital of Chicago

    Chicago, Illinois

  • Boston Children's Hospital

    Boston, Massachusetts

  • C.S. Mott Children's Hospital

    Ann Arbor, Michigan

  • Mayo Clinic

    Rochester, Minnesota

  • Columbia University Medical Center

    New York, New York

  • Montefiore Medical Center

    The Bronx, New York

  • Atrium Health

    Charlotte, North Carolina

  • Oregon Health and Science University

    Portland, Oregon

  • Cook Children's Medical Center

    Fort Worth, Texas

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.